The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.
Agostoni C, Nobile M, Ciappolino V, Delvecchio G, Tesei A, Turolo S, Crippa A, Mazzocchi A, Altamura CA, Brambilla P. (2017) Int J Mol Sci. 18(12). pii: E2608. doi: 10.3390/ijms18122608.
Web URL: View this and related abstracts via PubMed here, Free full text of this article is available online
Abstract:
In this systematic review, we will consider and debate studies that have explored the effects of ω-3 polyunsaturated fatty acids (PUFAs) in three major, and somehow related, developmental psychiatric disorders: Autism, Attention Deficit and Hyperactivity disorder and Psychosis.The impact of ω-3 PUFAs on clinical symptoms and, if possible, brain trajectory in children and adolescents suffering from these illnesses will be reviewed and discussed, considering the biological plausibility of the effects of omega-3 fatty acids, together with their potential perspectives in the field.
Heterogeneity in study designs will be discussed in the light of differences in results and interpretation of studies carried out so far.
KEYWORDS:
PUFAs; attention deficit hyperactivity disorder (ADHD); autism; docosahexaenoic acid (DHA); eicosapentaenoic acid (EPA); first psychotic episode; neurodevelopment; omega-3; ultra-high risk for psychosis
FAB RESEARCH COMMENT:
This open-access systematic review summarises the latest evidence for the effects of dietary supplementation with omega-3 fatty acids for ADHD, autism and early-stage psychosis / schizophrenia.While these conditions obviously have their differences, they also show notable overlaps in terms of both symptomatology and risk factors - both with each other, and also with other neurodevelopmental and psychiatric disorders. Considering them together therefore makes sense, as does a possible role for relative deficiencies of omega-3 fatty acids in these conditions, as has been emphasised before:
As the authors of this new review emphasise, most randomized controlled trials in this area remain small (and thus lacking in 'statistical power') as well as of short duration. They also vary widely in the actual populations studied, formulations and dosages of fatty acids used, and the outcomes assessed, making it difficult to combine or compare findings in many cases.
The current evidence indicates some benefit from omega-3 for 'ADHD-type' symptoms. For autism and psychosis, findings are more limited and mixed, but include possible reductions in medications needed. The authors conclude that more large-scale trials are still needed, but that further research in these areas is well justified.
See also:
And for more research involving randomized controlled trials of omega-3 for symptoms of ADHD, ASD, psychosis and related conditions, see:
Food and Behaviour Research is a registered charity (No SC034604) and a company limited by guarantee (Co No SC 253448)
Newsletter Signup
Useful Links
Contact Us
FAB Research
23 Carlton Road
Oxford
OX2 7SA
Important Notice
Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.
Site by Redstone Websites. Easy to Use Web Content Management. 2024 © All Rights Reserved.